BBC reports that researchers, from the drug company Merck, isolated platensimycin from a sample of South African soil. More significantly it showed activity against a variety of drug-resistant organisms, including MRSA.
If it passes clinical trials, it will become only the third entirely new antibiotic developed in the last four decades.
